SCHEMBL6706472

SCHEMBL6706472

COC(=O)C1(N2CCCCC2)CCN(Cc2ccccc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.70
ALDH1A1 P00352 5/20 0.54
CYP2D6 P10635 7/20 0.51
NPFFR1 Q9GZQ6 1/20 0.48
NPFFR2 Q9Y5X5 1/20 0.48
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
DPP7 Q9UHL4 1/20 0.46
USP2 O75604 1/20 0.46
MAPK1 P28482 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM3 P20309 1/20 0.46
MMP1 P03956 1/20 0.46
MMP9 P14780 1/20 0.46
MMP13 P45452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29239819 0.88 TSHR (0.53) TSHRALDH1A1CYP2D6CYP3A4CYP2C9
SCHEMBL6706403 0.85 TSHR (0.80) TSHRALDH1A1CYP2D6NPFFR1NPFFR2
SCHEMBL4934520 0.85 TSHR (0.70) TSHRALDH1A1CYP2D6NPFFR1NPFFR2
SCHEMBL4630100 0.83 TSHR (1.00) TSHRALDH1A1CYP2D6HRH3MEN1
SCHEMBL4942336 0.82 TSHR (0.70) TSHRALDH1A1CYP2D6NPFFR1NPFFR2
SCHEMBL4610766 0.82 TSHR (0.74) TSHRALDH1A1CYP2D6NPFFR1NPFFR2
SCHEMBL3934485 0.81 TSHR (0.97) TSHRALDH1A1CYP2D6CYP3A4HRH3
SCHEMBL4610565 0.80 TSHR (0.71) TSHRALDH1A1CYP2D6CYP3A4CYP2C19
SCHEMBL4032706 0.80 TSHR (0.57) TSHRALDH1A1CYP2D6NPFFR1NPFFR2
SCHEMBL3498095 0.80 CYP2D6 (0.56) TSHRALDH1A1CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof NPY1R, ADCY1, SRD5A1 TSHR 832/4885ALDH1A1 102/4885CYP2D6 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.